Phase 1 Study Of Anitocabtagene Autoleucel For The Treatment Of Patients With Relapsed And/Or Refractory Multiple Myeloma: Results From At Least 1-year Follow-up In All Patients

被引：0
|
作者：
Frigault, Matthew [1 ]
Rosenblatt, Jacalyn [2 ]
Dhakal, Binod [3 ]
Raje, Noopur [1 ]
Cook, Danielle [4 ]
Gaballa, Mahmoud [5 ]
Emmanuel-Alejandro, Estelle [2 ]
Nissen, Danielle [6 ]
Banerjee, Kamalika [7 ]
Rotte, Anand [7 ]
Heery, Christopher [7 ]
Avigan, David [2 ]
Jakubowiak, Andrzej [8 ]
Bishop, Michael [8 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Med Coll Wisconsin, Dept Med, BMT & Cellular Therapy Program, Milwaukee, WI 53226 USA
[4] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[7] Arcellx Inc, Redwood City, CA USA
[8] Univ Chicago, Chicago, IL 60637 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA-30
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [21] A 1-year follow-up study of coping in patients with panic disorder
    Hino, T
    Takeuchi, T
    Yamanouchi, N
    COMPREHENSIVE PSYCHIATRY, 2002, 43 (04) : 279 - 284
  • [22] Predictors of a favourable outcome in patients with fibromyalgia: results of 1-year follow-up
    Kim, J. -E.
    Park, D. -J.
    Choi, S. -E.
    Kang, J. -H.
    Yim, Y. -R.
    Lee, J. -W.
    Lee, K. -E.
    Wen, L.
    Kim, S. -K.
    Choe, J. -Y.
    Lee, S. -S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : 521 - 526
  • [23] 1-Year clinical and endoscopic follow-up of vedolizumab therapy in refractory PIBD patients
    Jongsma, M. M. E.
    Aardoom, M. A.
    de Ridder, L.
    Escher, J. C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S452 - S452
  • [24] Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy
    Ben-Menachem, E
    Gilland, E
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2003, 12 (03): : 131 - 135
  • [25] Ketamine for refractory chronic pain: a 1-year follow-up study
    Corriger, Alexandrine
    Voute, Marion
    Consortium, Okapi
    Lambert, Celine
    Pereira, Bruno
    Pickering, Gisele
    PAIN, 2022, 163 (04) : 690 - 701
  • [26] CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel in relapsed/Refractory multiple myeloma
    Madduri, Deepu
    Berdeja, Jesus
    Usmani, Saad
    Jakubowiak, Andrzej
    Agha, Mounzer
    Cohen, Adam
    Stewart, A. Keith
    Hari, Parameswaran
    Htut, Myo
    O'Donnell, Elizabeth
    Munshi, Nikhil
    Avigan, David
    Deol, Abhinav
    Lesokhin, Alexander
    Singh, Indrajeet
    Zudaire, Enrique
    Yeh, Tzu-Min
    Allred, Alicia
    Olyslager, Yunsi
    Banerjee, Arnob
    Goldberg, Jenna
    Schecter, Jordan
    Jackson, Carolyn
    Deraedt, William
    Zhuang, Sen Hong
    Infante, Jeffrey
    Geng, Dong
    Wu, Xiaoling
    Carrasco-Alfonso, Marlene
    Akram, Muhammad
    Hossain, Farah
    Rizvi, Syed
    Fan, Frank
    Jagannath, Sundar
    Lin, Yi
    Martin, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 16 - 17
  • [27] A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma
    Watanabe, Takashi
    Tobinai, Kensei
    Matsumoto, Morio
    Suzuki, Kenshi
    Sunami, Kazutaka
    Ishida, Tadao
    Ando, Kiyoshi
    Chou, Takaaki
    Ozaki, Shuji
    Taniwaki, Masafumi
    Uike, Naokuni
    Shibayama, Hirohiko
    Hatake, Kiyohiko
    Izutsu, Koji
    Ishikawa, Takayuki
    Shumiya, Yoshihisa
    Kashihara, Tomohisa
    Iida, Shinsuke
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (05) : 745 - 756
  • [28] Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma
    Sun, Mingyuan
    Jing, Hongmei
    Qu, Xiaoyan
    Dong, Fei
    Li, Yi
    Feng, Zhaoyi
    Ziti-Ljajic, Samira
    Semiond, Dorothee
    Li, Lingyu
    Qi, Junyuan
    Qiu, Lugui
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [29] A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients
    Berenson, James R.
    Kim, Clara
    Bujarski, Sean
    To, Jennifer
    Spektor, Tanya M.
    Martinez, Daisy
    Turner, Carley
    Ghermezi, Matthew
    Eades, Benjamin M.
    Swift, Regina A.
    Schwartz, Gary
    Eshaghian, Shahrooz
    Moss, Robert A.
    Lim, Stephen
    Vescio, Robert
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 906 - 913
  • [30] A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
    Lee, Hans C.
    Shah, Jatin J.
    Feng, Lei
    Manasanch, Elisabet E.
    Lu, Rebecca
    Morphey, Ashley
    Crumpton, Brandon
    Patel, Krina K.
    Wang, Michael L.
    Alexanian, Raymond
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    BLOOD CANCER JOURNAL, 2019, 9 (10)
12345